Your shopping cart is currently empty

CARM1/HDAC2-IN-1 (Compound CH-1) is a dual inhibitor targeting CARM1 and HDAC2, with IC50 values of 3.71 nM and 4.07 nM, respectively. This compound exhibits antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | CARM1/HDAC2-IN-1 (Compound CH-1) is a dual inhibitor targeting CARM1 and HDAC2, with IC50 values of 3.71 nM and 4.07 nM, respectively. This compound exhibits antitumor activity. |
| Targets&IC50 | HDAC2:4.07 nM, CARM1:3.71 nM |
| In vitro | CARM1/HDAC2-IN-1 inhibits the proliferation of human prostate cancer cells DU145, RM1, LAPC4, 22RV1, and PC-3, with IC50 values of 0.09 μM, 0.71 μM, 0.68 μM, 0.95 μM, and 0.43 μM, respectively. |
| In vivo | CARM1/HDAC2-IN-1 (administered via intraperitoneal injection at 0-20 mg/kg every four days for a total of six injections) demonstrates dose-dependent in vivo antitumor activity. |
| Formula | C35H42N8O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.